Delivery Order SPE2DB20D3101-SPE2DB24FRVV4
Award Date
9/23/24
Potential Completion Date
9/24/24
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D3101|SPE2DB24FRJC1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,218.12 firm fixed-price delivery order contract covers the supply of CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product, with a period of performance through May 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,130.99, is a Delivery Order contract for the supply of CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,415.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567379879 CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of February 26, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,686.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565047978 - CLOBAZAM 2.5 MG/ML SUSPENSION 120ML. The contract has an ultimate completion date of July 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,588.42 firm fixed-price delivery order is for the supply of 4567796165 CLOBAZAM 10 MG TABLET 100S, with a performance period through April 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
This federal contract award with ID SPE2DB20D1100|SPE2DB25FA2Y6 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,166.60 firm fixed-price delivery order contract is for the delivery of 4567072342 CLOBAZAM 10 MG TABLET 100S, with a performance period through January 29, 2025. The contract is not designated with any set-aside requirements, indicating open competition....
This federal contract award, valued at $5,655.37, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of 4564541392 - CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product, to a location...
This federal contract award, SPE2DB20D3103|SPE2DB25FL9D0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566637317 CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product. The contract has a ceiling value of $2,016.90 and is a Firm Fixed Price Delivery Order, with a performance period that ends on December 9, 2024. The contract is not designated as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,856.52 firm fixed-price delivery order is for the supply of 4566748542 - CLOBAZAM 10 MG TABLET 100S, with a period of performance through December 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award, with ID SPE2DB20D1051|SPE2DB25FD5WG, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,667.79 firm-fixed-price delivery order is for the supply of 4566120947 CLOBAZAM 10 MG TABLET 100S, with an ultimate completion date of October 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...